Bank Hapoalim Bm Gilead Sciences, Inc. Transaction History

Bank Hapoalim Bm

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $316,585 - $398,051	-5,098 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $114,658 - $133,140	1,585 Added 45.12%	5,098 $392,000
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $220,019 - $281,812	3,513 New	3,513 $263,000
Q3 2019 Nov 01, 2019	SELL	$62.51 - $69.0 $245,289 - $270,756	-3,924 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $95,898 - $107,539	-1,550 Reduced 28.32%	3,924 $265,000
Q1 2019 May 07, 2019	SELL	$62.53 - $70.05 $32,202 - $36,075	-515 Reduced 8.6%	5,474 $356,000
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $90,083 - $117,552	1,488 Added 33.06%	5,989 $375,000
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $53,103 - $58,795	-745 Reduced 14.2%	4,501 $348,000
Q2 2018 Jul 24, 2018	SELL	$64.88 - $75.68 $385,971 - $450,220	-5,949 Reduced 53.14%	5,246 $372,000
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $733,280 - $893,949	-10,067 Reduced 47.35%	11,195 $844,000
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $722,955 - $848,646	-10,161 Reduced 32.34%	21,262 $0
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $46,943 - $55,640	651 Added 2.12%	31,423 $2.55 Million
Q2 2017 Aug 11, 2017	BUY	N/A	30,772	30,772 $2.18 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

Stay updated on Bank Hapoalim Bm with notifications on news.